Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01667419
What this trial is testing

Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma

Who this might be right for
Melanoma
Hoffmann-La Roche 498
Not applicableStudy completedNCT02178475
What this trial is testing

Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy

Who this might be right for
Chemotherapy-induced Febrile Neutropenia
Amgen 943
Not applicableStudy completedNCT05519930
What this trial is testing

Pancreatic Cancer Early Detection Registry

Who this might be right for
Pancreatic Cancer
Hoag Memorial Hospital Presbyterian 326
Large-scale testing (Phase 3)Study completedNCT02180867
What this trial is testing

Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery

Who this might be right for
Alveolar Soft Part SarcomaAngiomatoid Fibrous HistiocytomaAtypical Fibroxanthoma+33 more
National Cancer Institute (NCI) 140
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06678867
What this trial is testing

The Use of 5-ALA in Paediatric Patients With High Grade Brain Tumours

Who this might be right for
Brain Tumor
University College, London 80
Not applicableLooking for participantsNCT05792150
What this trial is testing

PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS

Who this might be right for
Female Breast Cancer
Women's Cancer Study Group GmbH 1,470
Early research (Phase 1)Looking for participantsNCT07469891
What this trial is testing

PRT12396 in Participants With Select Myeloproliferative Neoplasms

Who this might be right for
Polycythemia Vera (PV)Myelofibrosis (MF)Myeloproliferative Neoplasms (MPNs)+3 more
Prelude Therapeutics Incorporated 100
Not applicableStudy completedNCT04829890
What this trial is testing

Adjuvant Chemotherapy With Epirubicin, CMF, and Weekly Docetaxel or Weekly Paclitaxel in Patients With Resected High-risk Breast Cancer

Who this might be right for
Breast CancerAdenocarcinoma of Breast
Hellenic Cooperative Oncology Group 89
Testing effectiveness (Phase 2)WithdrawnNCT02424513
What this trial is testing

Positron Emission Tomography (PET) With [89]Zr-Df-IAb2M in Patients With High-risk Prostate Cancer

Who this might be right for
Prostate Cancer
ImaginAb, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT06818682
What this trial is testing

Reduced Length of ADT and ARTA With XRT in High-Risk Prostate Cancer (RELAX): A Randomised Trial

Who this might be right for
Prostate Carcinoma
Tata Memorial Centre 206
Not applicableLooking for participantsNCT03116412
What this trial is testing

Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of High Risk Melanoma

Who this might be right for
Malignant Melanoma
Uppsala University 1,300
Large-scale testing (Phase 3)Ended earlyNCT04326764
What this trial is testing

Panobinostat Maintenance After HSCT fo High-risk AML and MDS

Who this might be right for
Acute Myeloid Leukaemia (AML)Myelodysplastic Syndromes (MDS)
Goethe University 52
Not applicableStudy completedNCT06576232
What this trial is testing

Standalone Observational Study Assessing the Performance of an AI/ML Tech-based SaMD on Chest LDCT Images (REALITY)

Who this might be right for
High Risk Cancer
Median Technologies 1,147
Not applicableStudy completedNCT00751816
What this trial is testing

Head & Neck Cancer Survivorship: Physical and Functional Status

Who this might be right for
Head and Neck Cancer
Vanderbilt University 23
Large-scale testing (Phase 3)Study completedNCT01696084
What this trial is testing

Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia

Who this might be right for
High Risk Acute Myeloid Leukemia
Jazz Pharmaceuticals 309
Testing effectiveness (Phase 2)Looking for participantsNCT05775471
What this trial is testing

Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer

Who this might be right for
Renal Pelvis and Ureter Urothelial Carcinoma
Jonsson Comprehensive Cancer Center 21
Testing effectiveness (Phase 2)UnknownNCT05514314
What this trial is testing

Prospective Study to Assess the Effects of Adjuvant Icotinib in EGFRm Stage I NSCLC With High-risk of Disease Recurrence After Complete Resection

Who this might be right for
Non-Small Cell Lung Cancer
Wu Nan 90
Early research (Phase 1)Active Not RecruitingNCT02353819
What this trial is testing

Stereotactic Ablative Radiotherapy (SABR) of Pelvis and Prostate Targets For High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Texas Southwestern Medical Center 60
Testing effectiveness (Phase 2)Study completedNCT02109744
What this trial is testing

Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients

Who this might be right for
Acute Myelogenous Leukemia
University of Rochester 27
Not applicableStudy completedNCT04723121
What this trial is testing

Can We Predict of the Response of High Risk Non Muscle Invasive Bladder Cancer Patients to Intravesical Bacillus Calmette-Guerin? The Role of Immunological Markers

Who this might be right for
Bladder Cancer
Mansoura University 204
Next Page